Drokhlyansky E, Smillie CS, Van Wittenberghe N, et al. The Human and Mouse Enteric Nervous System at Single-Cell Resolution. Cell. 2020;182(6):1606-1622.e23. doi:10.1016/j.cell.2020.08.003.

Kaiser T, Zhou Y, Feng G. Animal models for neuropsychiatric disorders: prospects for circuit intervention. Curr Opin Neurobiol. 2017;45:59-65. doi:10.1016/j.conb.2017.03.010.

Ahfeldt T, Litterman NK, Rubin LL. Studying human disease using human neurons. Brain Res. 2017;1656:40-48. doi:10.1016/j.brainres.2016.03.051.

Chan B, Cottrell JR, Li B, et al. Development of a high-throughput AlphaScreen assay for modulators of synapsin I phosphorylation in primary neurons. J Biomol Screen. 2014;19(2):205-14. doi:10.1177/1087057113505905.

van der Merwe C, Mwesiga EK, McGregor NW, et al. Advancing neuropsychiatric genetics training and collaboration in Africa. Lancet Glob Health. 2018;6(3):e246-e247. doi:10.1016/S2214-109X(18)30042-1.

Trynka G, Sandor C, Han B, et al. Chromatin marks identify critical cell types for fine mapping complex trait variants. Nat Genet. 2013;45(2):124-30. doi:10.1038/ng.2504.

Medland SE, Jahanshad N, Neale BM, Thompson PM. Whole-genome analyses of whole-brain data: working within an expanded search space. Nat Neurosci. 2014;17(6):791-800. doi:10.1038/nn.3718.

McCarroll SA, Feng G, Hyman SE. Genome-scale neurogenetics: methodology and meaning. Nat Neurosci. 2014;17(6):756-63. doi:10.1038/nn.3716.

Fox IJ, Daley GQ, Goldman SA, Huard J, Kamp TJ, Trucco M. Stem cell therapy. Use of differentiated pluripotent stem cells as replacement therapy for treating disease. Science. 2014;345(6199):1247391. doi:10.1126/science.1247391.

Choi DW, Armitage R, Brady LS, et al. Medicines for the mind: policy-based "pull" incentives for creating breakthrough CNS drugs. Neuron. 2014;84(3):554-63. doi:10.1016/j.neuron.2014.10.027.